|
Communique — Documents — Home
This page contains links to external Web sites. The Treatment Improvement Exchange has no control over their content or availability.
Performance-Based Monitoring in Narcotic Addiction Treatment
Dorynne Czechowicz, M.D., National Institute on Drug Abuse (NIDA); Laura Graham, M.P.A., Quintiles, Inc.; and
Bill Luckey, Ph.D., Research Triangle Institute (RTI)
Narcotic addiction treatment is a
vital component of the national effort to reduce opioid and injection drug
use and its consequences. The quality and outcomes of narcotic addiction
treatment are, therefore, of great importance to the alcohol and other drug
(AOD) abuse treatment field. A performance-based measurement system
in narcotic addiction treatment programs has the potential to help clinics
improve the services they deliver to their patients.
The National Institute on Drug Abuse/National Institutes of Health
(NIDA/NIH) is funding a study called the Methadone Treatment Quality
Assurance System (MTQAS) that is designed to determine the feasibility
and usefulness of a performance-based feedback system for narcotic
addiction treatment programs. The study is being conducted by the Research
Triangle Institute (RTI) in collaboration with the Center for Substance Abuse
Treatment (CSAT) and the National Association of State Alcohol and Drug Abuse
Directors (NASADAD).
Focus on Quality
Treatment program staff are concerned with quality improvement. In
addition, managed care entities and payers are increasingly interested in
managing costs and quality for the purpose of achieving optimal value for the
dollars spent and services provided. Though many measurement, data
management, and reporting methods and tools were developed for the primary
health care field, they are just now being used by the substance abuse
treatment field.
In assessing quality, one challenge has been how to define and
identify appropriate indicators of quality improvement. Performance indicators
are most useful if they are defined and measurable, can be tracked over
time, and accurately reflect the treatment process.
MTQAS is designed as an outcomes-based monitoring system that
tracks program performance over time based on patient outcomes. Phase I
of MTQAS, which ended in July 1995, focused on designing the system
and testing a prototype for a limited time in a relatively small number of clinics.
Phase II is a full-scale assessment of the feedback system in which
many narcotic addiction treatment clinics in seven States participated. Data
collection began in 1996 and continued through 1998. Study staff are
analyzing both quantitative and qualitative data to understand what is required
to implement and operate such a system and to determine how programs
and States use the information.
Phase I: Defining Indicators
Phase I of MTQAS answered several key questions:
Which performance indicators, including treatment outcomes,
can usefully serve as the basis for a performance measurement system?
This system must be capable of comparing client outcomes
fairly across clinics by adjusting for a program's "case-mix" (that is,
by separating the contribution of client characteristics from the
program's performance).
How might performance feedback be structured so that it provides
the greatest assistance to clinics? What operational problems
might arise if such a system were implemented?
In devising a strategy to answer
these questions, MTQAS staff consulted an advisory panel of providers,
researchers, quality assurance experts, representatives from national health
professional organizations, and Federal agency representatives. Staff
then developed a client-level data collection instrument (Client Assessment
Profile or CAP) that was field tested in Phase I. The first part of the field test
was conducted in five narcotic addiction treatment clinics. Based on
inter-rater reliability tests and clinician
ratings, the items in the CAP proved to have both high validity and reliability.
The second part of the field test involved a controlled 6-month test of
the performance reporting system in 25 narcotic addiction treatment clinics
in 16 States and the District of Columbia. Program staff collected data on
approximately 1,200 patients and provided one feedback report to
each participating clinic. The feedback report contained descriptive data
about each program's patients and, based on case-mixed data, provided
quintile ranks for each outcome. MTQAS staff met with program directors to
obtain feedback about their experience participating in MTQAS and about
the usefulness of the information provided to them.
Phase I Findings
Phase I resulted in good information about which outcomes form the
basis for a performance monitoring system and which patient-level information
is necessary to case-mix the data. Additionally, the Phase I program
directors had a significant impact on the structure of Phase II, particularly the
operational issues associated with MTQAS and the structure and format of
the performance feedback.
Phase II: Testing the System
Phase II was a full-scale
assessment of the MTQAS system. Phase II's goals were to:
Determine whether a performance-based system can be
implemented in narcotic addiction treatment clinics on an
ongoing basis and identify any operational problems with
such a system.
Assess whether performance feedback either alone or in
combination with technical assistance can be used to guide changes
in clinic processes or procedures that will enhance the quality of care
provided.
Assess the efficacy of the MTQAS system for improving selected
in-treatment outcomes (that is, outcomes that should be rapidly
influenced by relatively minor changes in clinical protocols, such as
dosing policies).
MTQAS Phase II was innovative for several reasons. First, Phase II
was implemented in 7 States and approximately 80 clinics, over a third of
which were private. Nearly 80 percent of clinics in the States participated
to some degree. Second, the study involved a partnership among
providers, the States, and the research community. Clinic staff collected intake
and quarterly follow-up information on all patients in narcotic addiction
treatment over a period of 18 months. Each State processed the data as it
was received from its clinics, and sent a data file to RTI for analysis and
production of the Quarterly Performance Feedback Reports. Finally,
CSAT provided technical assistance to a sample of the participating
clinics whose outcomes were below expectations.
The MTQAS study design allowed for comparisons across clinics,
across funding and regulatory environments, and across time. Seven States
participated: Arizona, Colorado, Georgia, Massachusetts, North Carolina,
Pennsylvania, and Washington. MTQAS was implemented statewide in each,
in both public and private clinics. Pennsylvania had some difficulty
implementing this approach because of changes in the public health care
system, and eventually discontinued data collection. Reassessments were
ongoing, with quarterly performance feedback reports provided to the clinics.
Ten clinics also received technical assistance (TA) through CSAT to
translate the MTQAS feedback into action. A standardized, on-site
assessment was conducted at clinics selected for TA by an experienced narcotic
addiction treatment provider to develop the TA plan. The TA delivery occurred
in early 1998.
The MTQAS study fostered discussion among the narcotic addiction
clinics, State offices, CSAT, NIDA, and the research community. Such
communication is important to determine how the performance-based outcome
information can best be used for improving the quality of narcotic addiction
treatment.
In addition to producing the feedback reports, RTI staff also assessed
the implementation of MTQAS through quarterly calls to State staff. RTI
staff were interested in learning what challenges were encountered and how
they were being addressed during the MTQAS implementation. Study
staff are to visit each of the States at the conclusion of the study to meet
with providers and State staff. These meetings are designed to obtain a
better understanding of what it took to implement MTQAS, the usefulness of
the feedback reports, including both the value and limitations of the
information, and how the system might be improved.
Description of MTQAS Assessments
The performance feedback reports were based on patient-level data
collected by clinic staff. Most items
necessary for the performance feedback reports were items that a
clinician would ask as part of a routine assessment. The experience in Phase I
demonstrated that if MTQAS were to be successful, the system needed to
be embedded within clinic operations. Clinics sent their data to their
State office, which acted as a clearinghouse for the data. In each State office,
a contact person was responsible for shipping the data to RTI on a
monthly basis. The MTQAS assessment schedule for each patient included
the following:
An initial assessment. This contained the key pieces of
information to provide baseline measures for outcomes, as well as other
patient characteristics that were used to adjust for differences in the types
of patients served when making comparisons across participating
clinics (that is, the case-mix adjustment). MTQAS staff selected these
items on the basis of previous research, including Phase I of MTQAS.
The initial assessment, completed at admission, took no more than
10 minutes.
Periodic reassessments. These included items based on
interviews, as well as items recorded from the patient record. These
follow-up items were required for the outcome analyses and included
in-treatment behaviors, such as drug use, injecting behavior, arrests, and
urinalysis results. These measures were commonly applied to drug
treatment outcomes. The measures were also useful for a counselor to ask
and observe during regular treatment plan reviews. Actual timing of
the periodic reassessments was determined for each patient according
to the date of admission. Reassessments were conducted on a
quarterly basis for patients who had been in treatment less than 1
year ("shorter term") and biannually for patients who had been in
treatment more than 1 year ("longer term").
The periodic reassessments, including completing the record data,
took approximately 10 minutes per patient.
Client profile. Five items on
client demographics were collected one time only from patients already
in treatment when the MTQAS data collection began. These five
items were necessary for the minimal case-mix adjustment methods.
Client discharge. The discharge information collected included
the date and reason for discharge. This information, extracted from the
patient record, was completed when a patient left a clinic.
The Case-Mix Adjustment Process
One important reason that
outcomes may differ across clinics is that clinics serve different types of patients.
Case-mix adjustment is a way of leveling the playing field when
comparing outcomes across clinics that have different patient populations.
Case-mix adjustment is used to look at patient outcomes in a wide range
of service settings: hospitals, nursing homes, home health agencies,
ambulatory care settings, and mental health clinics. In MTQAS, this process
was used to adjust for different patient populations when comparing or
ranking clinics according to their patients' outcomes.
Case-mix adjustment involves a
statistical analysis in which patient characteristics and baseline behaviors
are used to predict patient outcomes. For each outcome, a different
statistical model is used. For example, one of the outcomes is "no arrests." How
well each clinic does on this outcome is estimated, while adjusting for a
number of factors that may affect patients' arrest rates. These factors
include patients' age, gender, race, current criminal justice status, and arrest
history.
MTQAS Indicators/Outcomes
MTQAS used a variety of outcomes as part of the performance reporting
system. An important part of the study's development was determining which outcomes would be most
appropriate to include in a performance feedback system. The MTQAS outcomes
included self-reported drug-using behaviors and results from urine tests,
as well as social functioning, physical and mental health, utilization of
medical services, the patient's satisfaction with services, and retention in treatment.
MTQAS staff selected these outcomes on the basis of MTQAS Phase I
results, discussions with the participating State staff and advisory
panel members, and a review of pertinent literature. Indicators were selected for the core MTQAS data set. In addition to this core set of
outcomes, many States have opted to add other items to their data set.
These include HIV-risk behaviors, social support, and the use of
other drugs, such as methamphetamine and alcohol.
Application of MTQAS to Other Treatment Modalities
Although MTQAS has been developed for and is being tested in narcotic
addiction treatment clinics, many of this system's attributes make it
applicable to other treatment modalities. This new system provides data on
measurable outcomes, tracks performance over time, and uses indicators
related to the treatment process. Furthermore, some of the outcomes are
associated with changes in costs and may be useful in a cost-offset model.
The indicators used in MTQAS are likely to be valuable both internally
to clinic staff and externally to payers and patients. MTQAS will assist
the treatment field in determining how best to implement a
performance-based system and how the feedback may
be used to implement changes in clinic practices.
 
Table of Contents
Last Updated
|